TransMedics Group (TMDX) Earnings Date & Reports

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states... Show more

Industry: #Medical Specialties

Get AI intraday signals

A.I. Advisor

published Earnings

TMDX is expected to report earnings to rise 35.11% to 25 cents per share on May 06

TransMedics Group TMDX Stock Earnings Reports

Q1'25

Est.

$0.26

Q4'24

Beat

by $0.03

Q3'24

Missed

by $0.17

Q2'24

Beat

by $0.14

Q1'24

Beat

by $0.38

The last earnings report on February 27 showed earnings per share of 18 cents, beating the estimate of 15 cents. With 1.12M shares outstanding, the current market capitalization sits at 2.40B.

View a ticker or compare two or three

Compare

TMDX